ArticleTranslational andrology and urology2025
Features associated with 90-day in-person follow-up care after virtual visits in urology.
Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The coronavirus disease 2019 (COVID-19) pandemic created a paradigm shift in healthcare delivery with rapid utilization of telehealth in urology. Despite cessation of pandemic policies, urologists continue to utilize telehealth at a high rate. While these visits can improve access and convenience for many, the degree to which they translate to in person encounters remains underexplored. This study aimed to evaluate features associated with in-person encounters following a virtual visit within our urology department. Methods: Telehealth visits in our department with a new or consult billing code between January 2022 and December 2023 were retrospectively identified. The primary outcome was follow-up for an in-person appointment within 90 days. Secondary outcome was the number of surgical procedures. Multivariable logistic regression was used to model associations between patient features and subsequent in-person care, using benign prostatic hyperplasia (BPH) as the referent category for visit diagnosis. Results: We identified 1,079 video visits, of whom 598 (55%) sought in-person care within 90 days. Following multivariable adjustment, patients living over 150 miles away [adjusted odds ratio (adjOR) 0.56, 95% confidence interval (CI): 0.41-0.78] and prostate cancer visits (adjOR 0.40, 95% CI: 0.30-0.65) were less likely to follow-up in-person. Among returning patients, 413 (69%) underwent urological surgery within 90 days. After multivariable adjustment, kidney cancer (adjOR 0.41, 95% CI: 0.23-0.72), elevated prostate-specific antigen (PSA) (adjOR 0.36, 95% CI: 0.23-0.56), and prostate cancer (adjOR 0.32, 95% CI: 0.22-0.47) were significantly less likely to pursue surgery than BPH visits. Conclusions: Patients with a shorter travel distance and those being seen for a vasectomy were more likely to pursue in-person care within 90 days after a telehealth visit than those seen for oncologic indications. These findings may be useful to other urology departments seeking to efficiently integrate virtual visits in resource-constrained environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.